My take on the dilution
Though I feel the short term oain as well as the rest of you, and perhaps more due to my and my clients fairly large position, I am looking ahead and see the following
I recall all the same rhetoric on this board when Aria last diluted our positions. Though I don't recall the exact price of the last offering, I do believe that we are about 30-40% higher today than before the last dilution.
I, for one, love the idea that Aria may not partner the major revenue stream from 534 and I can see this drug (of course if all goes well in the pivotal trial) earning a net of $3 to $4 a share. If this dilution is the price we must pay to posibly allow this to happen, I am all for it . Lets not be so short sighted.
As usual, this is JMHO
